| INTRODUC TI ON
Laboratory-confirmed Middle East respiratory syndrome coronavirus (MERS-CoV) has been documented in more than 2000 cases worldwide, causing 722 related deaths from September 2012 through September 2017. 1 Much research evidence is available on factors associated with a poor prognosis in laboratory-confirmed MERS-CoV [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] and non-MERS-CoV 9-11 patients. A high mortality rate was systematically recognized in MERS-CoV patients of old age, 2,12-15 severe illness, 2,12-14 underlying condition, 2, [12] [13] [14] and respiratory/gastrointestinal symptoms. 2 However, successful management of MERS-CoV such as clinical recovery and its predictors has not been given sufficient attention despite the virus having been in circulation since 2012.
As per the authors' knowledge, two studies have so far addressed clinical improvement on laboratory-confirmed MERS-CoV patients. 16, 17 The first study, Shalhoub et al, 16 was based on a case report in which their observations may not be generalized to a wider MERSCoV population. The second study, Al-Turaiki et al, 17 utilized publicly available data from the Saudi Ministry of Health. The major shortcomings in their study were several potential confounding factors such as underlying medical conditions and a primary or secondary mode of MERS-CoV transmission that had not been included in the analysis. In addition, the recovery delay was not reported in their study, and thus, factors related to the recovery delay were not examined. Early screening and diagnosis of MERS-CoV could greatly promote proper control and clinical management of cases, which may reduce the risk of transmission and increase the chance of successful outcomes. [18] [19] [20] This study provides more understanding of how long a period (in days) it may take to recover from MERS-CoV infection.
The authors have studied, retrospectively, a cohort of survivorslaboratory-confirmed MERS-CoV and non-MERS-CoV patients-to estimate recovery delay intervals and identify possible associated factors in Saudi Arabia. The authors assessed whether the time interval between presentation and the initial rRT-PCR diagnosis (diagnosis delay) correlates with the time interval between initial rRT-PCR diagnosis and recovery (recovery delay). We hypothesized that older age, MERS-CoV infection, ICU admission, and abnormal radiology findings might be associated with longer recovery delay. We hypothesized that diagnosis delay might positively correlate with a recovery delay. From patient charts, we collected demographic data: age and gender. Elderly age was defined by classifying age into two groups using a cutoff of 65 years (≥65 years). The reason behind this classification was to assess the recovery delay for this vulnerable age group, as a previous study reported a high mortality rate in this group. 15 We collected data on route of transmission: camel contact 
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| Statistical analysis
The analysis was conducted using IBM Statistical Package for Social Sciences (SPSS) (24; SPSS, Chicago, IL). Patients' characteristics were described by count and percent, and mean (± standard deviation) or median where appropriate. Time intervals in days from presentation to initial rRT-PCR diagnosis (diagnosis delay) and from initial rRT-PCR diagnosis to recovery (recovery delay) were analyzed by Spearman's correlation coefficient.
The Poisson and negative binomial models were used to model the frequency of recovery delay in days and identify unadjusted and adjusted factors associated with longer recovery delay. Goodnessof-fit measures were used to compare and identify the best model.
The model with the smaller deviance, larger Log likelihood, smaller
Akaike information criterion, and smaller Bayesian information criterion was considered the better model. In all analyses, a P-value of less than 5% was considered significant. Relative risk (RR) and 95%
confidence intervals (CI) were used to assess the strength of association between patients' characteristics and longer/shorter recovery delay.
| RE SULTS
A total of 396 patients, suspected and screened for MERS-CoV by an rRT-PCR test, were analyzed. The average age was 46 years with age ranges between 1 and 95 years. The median recovery delay in our sample was 5 days. Of the sample, 57.7% were male and 18.4%
were admitted to ICU. Fever and respiratory symptoms were common presentations, occurring in 66.3% and 84.1% of the patients, respectively. The chest X-ray and/or CT scan were abnormal in almost half of the samples (48.4%). Refer to Table 1 for other sample parameters. The longer delays in diagnosis were positively correlated with longer recovery delay (r = .421; P = .001).
According to univariate negative binomial regression analysis ( A multivariate negative binomial regression analysis (Table 2) revealed six independent factors that affect the recovery delay. 
| D ISCUSS I ON
This is the first study identifying predictors of recovery delay (in 2 Furthermore, most MERS-CoV patients develop severe pneumonia 22 and necessitate mechanical ventilation, 11 which is a risk factor for hospital mortality. 23 Patients admitted to ICU admission were at higher risk for longer recovery delay. A previous report showing similar findings, longer ICU stay, and high mortality rate was reported in MERS-CoV patients who were admitted to the ICU. 24 Such patients would benefit from monitoring their responses to medical support and recognizing potential complications at an early stage.
We found that camel contact was associated with shorter recovery delay. Studies on recovery delay in patients with camel contact as compared to close contact exposure of a confirmed case or other exposure are lacking; however, camel contact has also been linked to lower 3-and 30-day mortality rates in MERS-CoV patients. 2 This important association requires more studies to identify whether camel contact is an independent protective factor of shorter recovery delay.
In our study, patients with respiratory symptoms are more likely to experience shorter recovery delay than patients without respiratory symptoms. This finding is probably related to the shorter lag time between symptom onset and diagnosis, in which patients with presence of symptoms could be positively affected by an early diagnosis 18 and thus prompt medical support is deemed necessary.
The time interval from presentation to initial rRT-PCR diagnosis (diagnosis delay) was positively correlated with the time interval from initial rRT-PCR diagnosis to recovery (recovery delay). Early diagnosis is likely to improve clinical outcomes 18 and reduce the economic and physical burden of a disease. 25, 26 Early diagnosis requires full utilization of hospital resources. Individuals at high risk of MERS-CoV infection should be promptly screened after arrival at the healthcare facility, monitored for progression, and then having a prompt decision made for whether further rRT-PCR testing is needed.
The authors noticed the following limitations. First, the study was based on chart reviews, and findings should be interpreted with caution. Second, we did not collect information on the type of antiviral treatment or other supportive treatments given after diagnosis which may have affected clinical outcomes. 27, 28 Third, despite this being the first investigation in this population, including a number 
| CON CLUS IONS
The study evidence supports that longer recovery delay was seen 
CONFLICT OF INTEREST
There are no conflict of interests. 
